Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca says high dose of Faslodex tops current dose at reducing breast cancer progression
AstraZeneca says high dose of Faslodex tops current dose at reducing breast cancer progression
AstraZeneca says high dose of Faslodex tops current dose at reducing breast cancer progression
Submitted by
admin
on December 11, 2009 - 10:35am
Source:
Yahoo/AP
News Tags:
breast cancer
Faslodex
AstraZeneca
Headline:
AstraZeneca says high dose of Faslodex tops current dose at reducing breast cancer progression
Do Not Allow Advertisers to Use My Personal information
